FIELD: medicine, oncology. SUBSTANCE: method involves carrying out an intradermal trial. To patient 0.1 ml mixture consisting of blood clot autofibrin in 0.9% sodium chloride solution is administrated followed by visual control of skin reaction 24 hr after mixture administration. Possibility of cancer illness is suggested in the case of reaction absence in patient. EFFECT: improved method of risk illness detection.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF FIBRIN PHYSIOLOGICAL SOLUTION PREPARING | 1992 |
|
RU2082410C1 |
| METHOD OF PREPARING ANTICARCINOMA SERUM | 1991 |
|
RU2009502C1 |
| METHOD OF PREPARING WATER-SOLUBLE FIBRIN POWDER | 1992 |
|
RU2057535C1 |
| METHOD FOR PRODUCTION OF HEMINE | 1991 |
|
RU2045267C1 |
| METHOD FOR PREPARATION OF FIBRINOUS FOAM | 1991 |
|
RU2033167C1 |
| CANCER THERAPY | 2008 |
|
RU2386442C2 |
| METHOD FOR MALIGNANT TUMOUR DISEASE RECURRENCE PREDICTION | 2015 |
|
RU2620306C2 |
| METHOD FOR SEPARATION FIBRIN FOR FRACTIONS | 2005 |
|
RU2303986C1 |
| PROCESS FOR MANUFACTURE OF FIBROUS FIBRIN | 1991 |
|
RU2032411C1 |
| METHOD OF FIBRIN FRACTION PREPARING | 1991 |
|
RU2056848C1 |
